Tenmizu FinTech

立康 6242

OTC · Biotechnology and medical care
Backtest

Sign up to add 立康 to your watchlist

Sign up to use the watchlist, price alerts and backtests, and keep your personalised settings.

Continue to sign up or sign in

Already have an account? Sign in

32▼-1.5 (-4.48%)After close
Prev close
33.5
Volume (shares)
2,000
Data time
2026-11-12 13:30:00
Open
32.00
High
32.00
Low
32.00
Prev close
33.50
Volume (lots)
2
Turnover
0.00 億
P/E
13.9
Cash yield
6.25%

Financial trends

Loading…

Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.

Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC

Loading…

Figures are shown as announced, with no scoring or rating.

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Gross margin66.95%67.02%67.35%67.63%67.55%67.92%67.84%67.95%
Operating margin16.70%10.53%19.87%11.20%19.07%14.51%19.04%14.92%
Net margin15.18%8.73%16.21%11.31%15.65%12.52%15.88%13.42%
ROE (TTM)9.12%8.86%9.71%9.81%10.44%9.36%10.37%11.45%
ROA (TTM)6.78%7.11%7.88%7.63%7.72%7.55%8.27%9.19%
EPS, quarter (TWD)0.780.330.880.420.810.530.820.54
EPS, TTM (TWD)2.412.442.642.582.702.572.482.67

MonthRevenueMoMYoYYTDYTD YoY
2026-100.526.39%-8.12%4.6-3.74%
2026-090.413.21%7.63%4.0-3.14%
2026-080.4-12.00%-0.50%3.6-4.24%
2026-070.4-15.63%-0.08%3.3-4.65%
2026-060.5-14.05%-8.33%2.8-5.29%
2026-050.67.19%7.94%2.3-4.62%
2026-040.51.13%-4.15%1.8-8.15%
2026-030.5119.50%-7.93%1.2-9.82%
2026-020.2-44.15%-44.55%0.7-11.25%
2026-010.4-20.29%33.56%0.433.56%
2025-120.5-7.40%3.33%5.94.19%
2025-110.62.61%10.18%5.34.28%

Revenue in NT$100M; 12 months per page.

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Revenue1.21.61.21.71.21.61.31.6
Cost of revenue0.40.50.40.60.40.50.40.5
Gross profit0.81.10.81.20.81.10.91.1
Operating expenses0.70.80.70.80.70.80.70.8
Operating income0.10.30.10.30.10.30.20.3
Non-operating items-0.00.00.00.00.00.00.00.0
Pre-tax income0.10.30.10.40.20.30.20.3
Income tax0.00.00.00.10.00.10.00.1
Continuing operations0.10.20.10.30.10.30.20.3
Net income0.10.20.10.30.10.30.20.3
Net income to parent0.10.20.10.30.10.30.20.3
Other comprehensive income0.10.0-0.0-0.0-0.0-0.0-0.0-0.0
Total comprehensive income0.20.30.10.30.10.30.10.3
EPS (TWD)0.320.780.330.880.420.810.530.82

Amounts in NT$100M (per-share items in NT$).

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Current assets2.32.52.52.53.24.15.25.1
Non-current assets10.08.98.48.48.47.15.75.2
Total assets12.311.410.910.911.611.210.910.4
Current liabilities1.52.41.61.72.62.31.30.9
Non-current liabilities2.10.50.50.50.50.60.80.9
Total liabilities3.63.02.12.23.12.82.21.8
Share capital3.23.23.23.23.23.23.23.2
Capital surplus2.12.12.12.12.12.12.12.1
Retained earnings3.43.33.73.63.33.23.53.4
Other equity-0.1-0.2-0.2-0.2-0.2-0.2-0.1-0.1
Equity to parent8.68.48.88.78.48.38.78.6
Total equity8.68.48.88.78.48.38.78.6
Book value per share (TWD)27.1526.5027.7127.3926.5226.1527.3626.90

Amounts in NT$100M (per-share items in NT$).

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Operating cash flow-0.10.2-0.00.7-0.10.10.20.5
Investing cash flow-0.60.00.0-0.7-0.5-0.20.6-0.5
Financing cash flow0.90.00.0-0.50.5-0.40.0-0.0
Net change in cash0.20.2-0.0-0.5-0.1-0.40.8-0.1
Cash, beginning0.40.40.40.60.60.60.61.1
Cash, ending0.80.60.40.41.01.01.50.6

Amounts in NT$100M (per-share items in NT$).

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Current ratio104.32%———————
Debt ratio25.94%19.39%20.29%27.09%25.46%20.09%17.37%16.47%
Equity ratio74.06%80.61%79.71%72.91%74.54%79.91%82.63%83.53%
Equity multiplier1.351.241.251.371.341.251.211.20

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Asset turnover (TTM revenue / avg. assets)0.510.530.550.540.530.540.610.64
Equity turnover0.680.660.680.700.720.660.760.80

Source: MOPS. For reference only; not investment advice.